Development and characterisation of highly antibiotic resistant Bartonella bacilliformis mutants
- PMID: 27667026
- PMCID: PMC5035977
- DOI: 10.1038/srep33584
Development and characterisation of highly antibiotic resistant Bartonella bacilliformis mutants
Abstract
The objective was to develop and characterise in vitro Bartonella bacilliformis antibiotic resistant mutants. Three B. bacilliformis strains were plated 35 or 40 times with azithromycin, chloramphenicol, ciprofloxacin or rifampicin discs. Resistance-stability was assessed performing 5 serial passages without antibiotic pressure. MICs were determined with/without Phe-Arg-β-Napthylamide and artesunate. Target alterations were screened in the 23S rRNA, rplD, rplV, gyrA, gyrB, parC, parE and rpoB genes. Chloramphenicol and ciprofloxacin resistance were the most difficult and easiest (>37.3 and 10.6 passages) to be selected, respectively. All mutants but one selected with chloramphenicol achieved high resistance levels. All rifampicin, one azithromycin and one ciprofloxacin mutants did not totally revert when cultured without antibiotic pressure. Azithromycin resistance was related to L4 substitutions Gln-66 → Lys or Gly-70 → Arg; L4 deletion Δ62-65 (Lys-Met-Tyr-Lys) or L22 insertion 83::Val-Ser-Glu-Ala-His-Val-Gly-Lys-Ser; in two chloramphenicol-resistant mutants the 23S rRNA mutation G2372A was detected. GyrA Ala-91 → Val and Asp-95 → Gly and GyrB Glu474 → Lys were detected in ciprofloxacin-resistant mutants. RpoB substitutions Gln-527 → Arg, His-540 → Tyr and Ser-545 → Phe plus Ser-588 → Tyr were detected in rifampicin-resistant mutants. In 5 mutants the effect of efflux pumps on resistance was observed. Antibiotic resistance was mainly related to target mutations and overexpression of efflux pumps, which might underlie microbiological failures during treatments.
Figures
Similar articles
-
Molecular Characterization of Fluoroquinolone-Resistant Bartonella bacilliformis.Pathogens. 2021 Jul 10;10(7):876. doi: 10.3390/pathogens10070876. Pathogens. 2021. PMID: 34358026 Free PMC article.
-
Molecular mechanisms of resistance to antibiotics in Bartonella bacilliformis.J Antimicrob Chemother. 2007 Jun;59(6):1065-70. doi: 10.1093/jac/dkm105. Epub 2007 Apr 21. J Antimicrob Chemother. 2007. PMID: 17449882
-
Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals.J Antimicrob Chemother. 2003 Apr;51(4):1001-5. doi: 10.1093/jac/dkg168. Epub 2003 Mar 13. J Antimicrob Chemother. 2003. PMID: 12654733
-
gyrA mutations in ciprofloxacin-resistant Bartonella bacilliformis strains obtained in vitro.Antimicrob Agents Chemother. 2003 Jan;47(1):383-6. doi: 10.1128/AAC.47.1.383-386.2003. Antimicrob Agents Chemother. 2003. PMID: 12499219 Free PMC article.
-
Ten Years of Routine α- and β-Globin Gene Sequencing in UK Hemoglobinopathy Referrals Reveals 60 Novel Mutations.Hemoglobin. 2016;40(2):75-84. doi: 10.3109/03630269.2015.1113990. Epub 2015 Dec 4. Hemoglobin. 2016. PMID: 26635043 Review.
Cited by
-
Adaptive Resistance Mutations at Suprainhibitory Concentrations Independent of SOS Mutagenesis.Mol Biol Evol. 2021 Sep 27;38(10):4095-4115. doi: 10.1093/molbev/msab196. Mol Biol Evol. 2021. PMID: 34175952 Free PMC article.
-
Design of Multiplex Lateral Flow Tests: A Case Study for Simultaneous Detection of Three Antibiotics.Biosensors (Basel). 2020 Feb 27;10(3):17. doi: 10.3390/bios10030017. Biosensors (Basel). 2020. PMID: 32120923 Free PMC article.
-
Unusual and Unconsidered Mechanisms of Bacterial Resilience and Resistance to Quinolones.Life (Basel). 2024 Mar 14;14(3):383. doi: 10.3390/life14030383. Life (Basel). 2024. PMID: 38541707 Free PMC article. Review.
-
Carrion's disease: an eradicable illness?Infect Dis Poverty. 2016 Dec 1;5(1):105. doi: 10.1186/s40249-016-0197-7. Infect Dis Poverty. 2016. PMID: 27903286 Free PMC article.
-
Multiple Mechanisms Confer Resistance to Azithromycin in Shigella in Bangladesh: a Comprehensive Whole Genome-Based Approach.Microbiol Spectr. 2022 Aug 31;10(4):e0074122. doi: 10.1128/spectrum.00741-22. Epub 2022 Jul 25. Microbiol Spectr. 2022. PMID: 35876510 Free PMC article.
References
-
- Angelakis E. & Raoult D. Pathogenicity and treatment of Bartonella infections. Int. J. Antimicrob. Agents 44, 16–25 (2014). - PubMed
-
- Ilher G. M. Bartonella bacilliformis: dangerous pathogen slowly emerging from deep background. FEMS Microbiol. Lett. 144, 1–11 (1996). - PubMed
-
- Huerta A., Salas M., Yarinsueca J. & Maguiña C. Enfermedad de Carrión grave complicada con leptospirosis aguda: reporte de un caso. Rev. Peru. Med. Exp. Salud Publ. 31, 380–384 (2014). - PubMed
-
- Maguiña C., García P. J., Gotuzzo E., Cordero L. & Spach D. H. Bartonellosis (Carrión’s Disease) in the modern era. Clin. Infect. Dis. 33, 772–779 (2001). - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
